Mustang Bio logo
Mustang Bio MBIO
$ 0.21 -0.87%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Mustang Bio Balance Sheet 2011-2024 | MBIO

Annual Balance Sheet Mustang Bio

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-3.74 M -71.7 M -108 M -95.6 M -48 M -16.5 M -35 M -27.2 M 3.57 M - - - -

Long Term Debt

1.98 M 3.33 M 1.68 M - 12.2 M - - - - - - - -

Long Term Debt Current

520 K 612 K 348 K 278 K 257 K - - - - - - - -

Total Non Current Liabilities

- - - 1.95 M 14 M 741 K 50 K - - - - - -

Total Current Liabilities

15.4 M 15.1 M 10.8 M 9.52 M 7.77 M 5.62 M 3.61 M 3.22 M - - - - -

Total Liabilities

17.6 M 46.1 M 12.8 M 11.5 M 21.8 M 6.36 M 3.66 M 3.22 M 4.13 M - - - -

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-381 M -329 M -252 M -185 M -125 M -79.1 M -48.4 M -17.1 M -4.47 M - - - -

Total Assets

17.7 M 92.4 M 125 M 110 M 73.4 M 42.8 M 63.5 M 27.5 M - - - - -

Cash and Cash Equivalents

6.23 M 75.7 M 110 M 97.8 M 61.4 M 17 M 35.5 M 27.5 M - - - - -

Book Value

123 K 46.3 M 112 M 98.4 M 51.7 M 36.4 M 59.8 M 24.3 M -4.13 M - - - -

Total Shareholders Equity

123 K 46.3 M 112 M 98.4 M 51.7 M 36.4 M 59.8 M 24.3 M -4.13 M - - - -

All numbers in USD currency

Quarterly Balance Sheet Mustang Bio

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

541 K 656 K 1.83 M 2.12 M 2.24 M 3.28 M 3.33 M 3.39 M 1.5 M 1.59 M 1.68 M 1.76 M 1.82 M 1.88 M 1.95 M 1.95 M 1.95 M 1.95 M 1.84 M 1.84 M 1.84 M 1.91 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

15.8 M 16.8 M 19.5 M 16.6 M 15.4 M 43.8 M 46.1 M 44.5 M 39.9 M 39.6 M 12.8 M 12.5 M 8.18 M 8.46 M 11.5 M 11.5 M 11.5 M 11.5 M 21.8 M 21.8 M 21.8 M 22 M 6.36 M 6.36 M 6.36 M 6.36 M 3.66 M 3.66 M 3.66 M 3.66 M 3.22 M 3.22 M 3.22 M 3.22 M 4.13 M 4.13 M - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-396 M -394 M -386 M -372 M -362 M -346 M -329 M -310 M -291 M -272 M -252 M -232 M -215 M -200 M -185 M -185 M -185 M -185 M -125 M -125 M -125 M -88.7 M -79.1 M -79.1 M -79.1 M -79.1 M -48.4 M -48.4 M -48.4 M -48.4 M -17.1 M -17.1 M -17.1 M -17.1 M -4.47 M -4.47 M - - - - - - - - - - - - - - - - - -

Total Assets

7.19 M 8.52 M 14.6 M 20.6 M 29.1 M 73.6 M 92.4 M 109 M 122 M 137 M 125 M 135 M 143 M 142 M 110 M 110 M 110 M 110 M 73.4 M 73.4 M 73.4 M 50.5 M 42.8 M 42.8 M 42.8 M 42.8 M 63.5 M 63.5 M 63.5 M 63.5 M 27.5 M 27.5 M 27.5 M 27.5 M - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

3.52 M 4.27 M 1.34 M 9.56 M 15.4 M 58.1 M 75.7 M 91.4 M 107 M 122 M 110 M 121 M 130 M 129 M 97.8 M 97.8 M 97.8 M 97.8 M 61.4 M 61.4 M 61.4 M 36.1 M 16.5 M 16.5 M 17 M 17 M 35.5 M 33.2 M 53.8 M 75 M 27.5 M 11.1 M - - - - - - - - - - - - - - - - - - - - - -

Book Value

-8.66 M -8.33 M -4.94 M 4.01 M 13.7 M 29.8 M 46.3 M 64.3 M 82 M 97.3 M 112 M 122 M 135 M 133 M 98.4 M 98.4 M 98.4 M 98.4 M 51.7 M 51.7 M 51.7 M 28.5 M 36.4 M 36.4 M 36.4 M 36.4 M 59.8 M 59.8 M 59.8 M 59.8 M 24.3 M 24.3 M 24.3 M 24.3 M -4.13 M -4.13 M - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

-8.66 M -8.33 M -4.94 M 4.01 M 13.7 M 29.8 M 46.3 M 64.3 M 82 M 97.3 M 112 M 122 M 135 M 133 M 98.4 M 98.4 M 98.4 M 98.4 M 51.7 M 51.7 M 51.7 M 28.5 M 36.4 M 36.4 M 36.4 M 36.4 M 59.8 M 59.8 M 59.8 M 59.8 M 24.3 M 24.3 M 24.3 M 24.3 M -4.13 M -4.13 M - - - - - - - - - - - - - - - - - -

All numbers in USD currency